Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells. - Wikidata - awgldk - TriplyDB

Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells.

Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells.

http://www.wikidata.org/entity/Q35457074

about

Neurotoxic effects of AZT on developing and adult neurogenesis Different rates of DNA replication at early versus late S-phase sections: multiscale modeling of stochastic events related to DNA content/EdU (5-ethynyl-2'deoxyuridine) incorporation distributions.DNA damage signaling, impairment of cell cycle progression, and apoptosis triggered by 5-ethynyl-2'-deoxyuridine incorporated into DNA.A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity.Dynamic metabolic labeling of DNA in vivo with arabinosyl nucleosides The Fingerprint of Anti-Bromodeoxyuridine Antibodies and Its Use for the Assessment of Their Affinity to 5-Bromo-2'-Deoxyuridine in Cellular DNA under Various Conditions Looking for ugly ducklings: The role of the stability of BrdU-antibody complex and the improved method of the detection of DNA replication.Quantification of cell cycle kinetics by EdU (5-ethynyl-2'-deoxyuridine)-coupled-fluorescence-intensity analysis Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine.Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model.Cycloadditions for Studying Nucleic Acids.Neural stem cells exposed to BrdU lose their global DNA methylation and undergo astrocytic differentiation.Phosphorylated 5-ethynyl-2'-deoxyuridine for advanced DNA labeling.EdU induces DNA damage response and cell death in mESC in culture.Intraspinal transplantation of subventricular zone-derived neural progenitor cells improves phrenic motor output after high cervical spinal cord injury.Different neural crest populations exhibit diverse proliferative behaviors.

P2860

Q30414740-8FDB4F3D-8ABB-4D19-BC7B-0F0EEA9E5284 Q31162457-44E66924-C439-4797-AEC2-A459D0E160F1 Q35014102-58AABFD9-F133-4734-ADA7-0FFA2EED98D6 Q35559189-F4356091-CB97-4674-98EC-0B0BD47A4417 Q35651069-610F26F7-AAF1-4A1D-BF47-4686E1A378BC Q35688169-2CFC6277-4DB1-4BF9-9FC2-CA7A4B229AC1 Q36328502-C2A977A1-8926-4FE4-AD66-BC465DA7FCC5 Q36361392-0B80FDE9-10CD-439A-B562-3F7082FCD78E Q38805955-1F57F5C6-E772-41BB-A311-633401E4AF24 Q38833930-4CBD9B5A-2AF3-4566-B747-15C0AD4CF520 Q38940121-B38F7109-732E-4052-8CF0-294BAE023D6D Q39387716-F546B6DA-5FC4-4F7B-99CF-DD53CECC8B69 Q42829357-AA0F5F5A-98D8-47D2-82E4-E93DB6EE3B76 Q43225795-2CA9F694-CEF0-43CA-8C9A-DF2CA29231BD Q48677106-F37D4C26-FCD0-4089-A6C5-ED777CD8783E Q53021494-84B3D449-AD85-4BF3-A777-5470AAD3D84B

P2860

Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells.

http://www.wikidata.org/entity/Q35457074

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Ethynyldeoxyuridine (EdU) supp ...... n of human glioblastoma cells.

@ast

Ethynyldeoxyuridine (EdU) supp ...... n of human glioblastoma cells.

@en

type

label

Ethynyldeoxyuridine (EdU) supp ...... n of human glioblastoma cells.

@ast

Ethynyldeoxyuridine (EdU) supp ...... n of human glioblastoma cells.

@en

prefLabel

Ethynyldeoxyuridine (EdU) supp ...... n of human glioblastoma cells.

@ast

Ethynyldeoxyuridine (EdU) supp ...... n of human glioblastoma cells.

@en

P1433

Q35457074-42FD8904-8413-4C35-A574-BC469B990181

P1476

Q35457074-458E5188-AA2A-4325-AA19-037B1B4D195D

P2093

Q35457074-46370591-45E1-443C-9736-F5808AE1B0C8

Q35457074-59928DA3-5970-4100-BB2E-D01E8442C4D3

Q35457074-9420FA32-A131-4727-BE30-C7F439CB76B9

Q35457074-A921E4C3-73BD-4A40-AD24-69CE78EE86B9

Q35457074-A990DCE5-89BA-4940-86EA-23E71FBAF3B5

Q35457074-D69F77A9-579F-42A5-8068-58BDA9F6343E

Q35457074-E63F92BA-F3BB-46DF-8110-FCC84C70A7F1

P2860

Q35457074-0C1D8650-FC42-4329-9AD0-A38FFC108375

Q35457074-123A01D3-7A54-4601-8AE0-635E23B2A5B7

Q35457074-187BE1D0-4D67-4502-83CD-1B678AB2F3C4

Q35457074-299F9A02-0EF8-42B1-BF24-722ED1895107

Q35457074-2A40CF52-182B-45E1-A29D-27D4DD0BF2E2

Q35457074-302D1D80-F62B-402B-9A29-F76B8528F93D

Q35457074-421B68CA-DB29-44AF-9702-308B5F1A35A5

Q35457074-4A92F180-4973-40D7-8832-1FAAF39D19FE

Q35457074-4B3E6AD4-9F77-4432-B78E-C11B0F6587D6

Q35457074-520143E3-AB36-4B90-9748-1121E0C39D5D

P2888

Q35457074-B7D36B6B-E0E9-4C35-9540-B25033BEE832

P304

Q35457074-8CF986A8-0FFE-4F24-A6C3-3789AEAC919A

P31

Q35457074-A5B63DA5-D3E2-481E-B662-D7B2E98CC34D

P356

Q35457074-037FED76-086D-4AA8-8BB1-546407AEE935

P433

Q35457074-9C51D9EF-78A2-47B5-8133-F68B26EB014C

P478

Q35457074-A11971D5-E9A6-4675-835B-5BDCEA78BB8E

P50

Q35457074-2F60E985-A1C1-4A8B-9848-236A790DDA0B

P577

Q35457074-0EE8F932-4EC9-457C-B10C-19075479D2C7

P5875

Q35457074-755D637B-AC71-4E29-9181-19DD32F2BFD3

P698

Q35457074-8586F760-21C7-4C98-9085-99012DBC71AD

P932

Q35457074-DF66A85E-ECFA-4F05-85E0-B93C946CDD72

P356

S11060-011-0621-6

P1433

Journal of Neuro-Oncology

P1476

Ethynyldeoxyuridine (EdU) supp ...... on of human glioblastoma cells

@en

P2093

Brent A Reynolds

http://www.w3.org/2001/XMLSchema#string

Eric D Laywell

http://www.w3.org/2001/XMLSchema#string

Erin M Dunbar

http://www.w3.org/2001/XMLSchema#string

Heather H Ross

http://www.w3.org/2001/XMLSchema#string

Lindsay H Levkoff

http://www.w3.org/2001/XMLSchema#string

Maryam Rahman

http://www.w3.org/2001/XMLSchema#string

Sebastien Millette

http://www.w3.org/2001/XMLSchema#string

P2860

The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

Induction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells.

Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.

Cell type specific applicability of 5-ethynyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry.

A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

P2888

s11060-011-0621-6

P304

485-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-011-0621-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Teresa Martin-Carreras

P577

2011-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51194064

http://www.w3.org/2001/XMLSchema#string

P698

21643840

http://www.w3.org/2001/XMLSchema#string

P932

3202677

http://www.w3.org/2001/XMLSchema#string